Basit öğe kaydını göster

dc.contributor.authorŞahin, Zafer
dc.contributor.authorOmurtag Özgen, Pınar Sinem
dc.contributor.authorRollas, Sevim
dc.date.accessioned2024-01-12T11:38:30Z
dc.date.available2024-01-12T11:38:30Z
dc.date.issued2023en_US
dc.identifier.citationŞahin, Z., Omurtag Özgen, P. S. ve Rollas, S. (2023). Importance and review of drug metabolite synthesis. İstanbul Journal of Pharmacy, 53(2), 251-269. https://dx.doi.org/10.26650/IstanbulJPharm.2023.1033045en_US
dc.identifier.issn2587-2087
dc.identifier.urihttps://dx.doi.org/10.26650/IstanbulJPharm.2023.1033045
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12133
dc.description.abstractPhase I and Phase II metabolic reactions are involved in the pharmacokinetic properties of drugs after administration. These reactions mainly aim to make drugs more polar and eliminate them safely. However, some of these metabolites have the potential to exhibit a toxicological effect. Industry and/or academia have to consider these metabolites in terms of their pharmacodynamic and pharmacokinetic properties. These metabolites are not only residual intermediates from the synthetic process of the main drug but also unique structures produced by metabolic enzymes in the human organism. Thus, metabolite synthesis by synthetic or semi-synthetic methods is a key feature in the pharmaceutical industry. In this review, synthetic methods of the metabolites from all known metabolic pathways are reviewed from the literature. It was observed that both synthetic and semi-synthetic methods require more attention as they are as important and complex as drug synthesis. Moreover, it showed that there was much more research available for Phase I than Phase II in the literature.en_US
dc.language.isoengen_US
dc.publisherIstanbul Universityen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectDrug Metaboliteen_US
dc.subjectMetabolismen_US
dc.subjectSynthesisen_US
dc.subjectOxidationen_US
dc.subjectPhase Ien_US
dc.subjectPhase IIen_US
dc.titleImportance and review of drug metabolite synthesisen_US
dc.typereviewen_US
dc.relation.ispartofİstanbul Journal of Pharmacyen_US
dc.departmentİstanbul Medipol Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü, Farmasötik Kimya Ana Bilim Dalıen_US
dc.authorid0000-0002-4144-6952en_US
dc.identifier.volume53en_US
dc.identifier.issue2en_US
dc.identifier.startpage251en_US
dc.identifier.endpage269en_US
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.26650/IstanbulJPharm.2023.1033045en_US
dc.institutionauthorRollas, Sevim
dc.identifier.wos001110261800009en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster